Palisade Bio (PALI) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Oppenheimer | Initiated Coverage | Outperform | $8.00 | Jul 23, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $7.00 | Apr 9, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 | Mar 26, 2026 |
| Stifel | Initiated Coverage | Buy | $5.00 | Feb 25, 2026 |
| B. Riley Securities | Initiated Coverage | Buy | $7.00 | Jan 9, 2026 |
| Clear Street | Initiated Coverage | Buy | $12.00 | Dec 30, 2025 |
| Piper Sandler | Initiated Coverage | Overweight | $25.00 | Dec 29, 2025 |
| Brookline Capital | Maintained | Buy | $16.00 | May 13, 2025 |
| Brookline Capital | Initiated Coverage | Buy | $38.00 | Nov 20, 2024 |
| Maxim Group | Maintained | Buy | $8.00 from $22.50 | Nov 13, 2024 |
| Maxim Group | Maintained | Buy | $22.50 | May 1, 2024 |
| Maxim Group | Maintained | Buy | $22.50 | Apr 16, 2024 |
| Maxim Group | Upgraded | Hold → Buy | $1.50 | Nov 17, 2023 |
| Ladenburg Thalmann | Maintained | Buy | $16.00 from $25.00 | May 16, 2023 |
Frequently asked questions
Is PALI a buy, sell, or hold?
Analysts covering Palisade Bio currently average a Buy rating: 10 buy, 0 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PALI?
On Jul 23, 2026, Oppenheimer initiated coverage of Palisade Bio at Outperform with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.